MRI-Guided SBRT Reduces GI Toxicities in Prostate Cancer

home / oncclub / mri-guided-sbrt-reduces-gi-toxicities-in-prostate-cancer

Amar U. Kishan, MD, provides insight on the phase 3 MIRAGE study (NCT04384770), which showed that the use of MRI-guided stereotactic body radiotherapy resulted in a significant reduction in acute genitourinary and gastrointestinal toxicity compared with standard computed tomography–guided radiation.